⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14955995 | 0.94 | — | — | |
| SCHEMBL14956326 | 0.94 | — | — | |
| SCHEMBL14955993 | 0.94 | — | — | |
| SCHEMBL14955805 | 0.92 | — | — | |
| SCHEMBL14955910 | 0.91 | — | — | |
| SCHEMBL18054753 | 0.90 | — | — | |
| SCHEMBL18054754 | 0.90 | — | — | |
| SCHEMBL14955983 | 0.90 | — | — | |
| SCHEMBL14955985 | 0.90 | — | — | |
| SCHEMBL14956256 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210299104-A1 | EXTENDED RELEASE INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF | Boehringer Ingelheim Animal Health USA Inc. (US) | 2021-09-30 | — | — | US | disclosed |